SIMCERE PHARMAC. GRP LTD (S2P) — Free Cash Flow Generation Index
SIMCERE PHARMAC. GRP LTD (S2P) has a Free Cash Flow Generation Index of 0.57x as of December 2025. Free cash flow of €1.15 Billion represents 1% of operating cash flow (€2.01 Billion). Explore SIMCERE PHARMAC. GRP LTD capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
SIMCERE PHARMAC. GRP LTD Free Cash Flow Generation Index (2022–2025)
Historical FCF Generation Index trend for SIMCERE PHARMAC. GRP LTD across 4 annual periods. For the full cash flow conversion analysis, see S2P cash flow metrics.
Annual Free Cash Flow Generation for SIMCERE PHARMAC. GRP LTD (2022–2025)
Year-by-year Free Cash Flow Generation Index for SIMCERE PHARMAC. GRP LTD. Check SIMCERE PHARMAC. GRP LTD total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.57x | €1.15 Billion | €2.01 Billion | €862.20 Million | ▲ +26.6% |
| 2024 | 0.45x | €628.54 Million | €1.39 Billion | €762.57 Million | ▲ +108.2% |
| 2023 | -5.49x | €-828.81 Million | €151.05 Million | €979.86 Million | ▼ -1199.0% |
| 2022 | 0.50x | €676.09 Million | €1.35 Billion | €678.00 Million | — |